Physician profile
Jefferey Sabloff
NPI 1801823703
$594.47
in general payments reported to CMS, 2019-2025
9 companies · $21.14 in 2025
The $21.14 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.25 · 2020: $70.37 · 2021: $263 · 2022: $172 · 2025: $21.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $330.96 | 2021-2022 | |
| Horizon Therapeutics Plc | $111.93 | 2020-2022 | |
| Smith+Nephew, INC. | $37.04 | 2019 | |
| Ibsa Pharma INC. | $32.54 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $30.21 | 2019 | |
| Orthofix Medical, INC. | $21.14 | 2025 | Physio-Stim |
| Wright Medical Technology, INC. | $18.21 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.44 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$81,103.49 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jefferey Sabloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.